4th Annual

mRNA Conference USA 2026

April 27 - 28, 2026 | Boston, Massachusetts, USA

April 27 - 28, 2026
Boston, Massachusetts, USA

view programarrow icon

Discover the highlights of the event

connect with usarrow icon

Get your questions answered by our team

become a partnerarrow icon

Join as a sponsor and reserve your booth

GLOBAL FORUM FOR MRNA-BASED THERAPEUTICS AND DRUG DEVELOPMENT

Welcome to mRNA Conference USA 2026, where global pharmaceutical and biotech leaders join industry experts to explore breakthroughs in mRNA therapeutics for vaccines, personalized medicine, and beyond.

The event explores the role of mRNA technology in developing novel treatments, covering the full spectrum from R&D to clinical trials, large-scale manufacturing, and commercialization. It highlights advancements in RNA modification, therapeutic delivery systems, and vaccine development, and showcases the latest progress in mRNA, siRNA, and miRNA-based therapeutics.

Join us to explore next-generation mRNA therapeutics, gain valuable insights, and connect with peers to help shape the future of medicine.

Key topics for 2026

Future of mRNA-based therapeutics for infectious diseases and beyond

Explore the potential of mRNA therapeutics as a transformative new class of drugs.

Breakthrough research in mRNA, siRNA, and miRNA-based therapeutics

Gain insights into how advancements in mRNA, siRNA, and miRNA are shaping the future of therapeutic applications.

Challenges in scaling mRNA vaccines manufacturing for global distribution

Analyze advanced methods for the rapid development and large-scale distribution of vaccines in response to pandemics.

Latest advancements in mRNA formulation and delivery technologies

Discover the latest advancements in therapeutic mRNA delivery as they progress from the laboratory to patient treatment.

AI and ML-driven approaches to enhance mRNA therapeutic design

Learn how advanced AI and machine learning algorithms, combined with data analytics, are accelerating therapeutic design and revealing new insights.

Regulatory and compliance considerations in mRNA clinical development

Understand key regulatory and compliance considerations for the approval of mRNA therapeutics.

100+

INDUSTRY TOPICS

8+

NETWORKING EVENTS

50+

LEADING EXPERTS

20+

Q&A SESSIONS

LogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogoLogo

they've attended our events

Lingyao Li

A highly efficient conference with valuable communication and discussions.

Lingyao Li
Sanofi
Jennifer Carl

Packed with excellent speakers.

Jennifer Carl
Velocity Clinical Research
Xinhua Yan

Fantastic speakers and location with a strong schedule.

Xinhua Yan
Moderna, Inc.
Ami Jo

The event showcased the key elements in drug product development.

Ami Jo
Omega Therapeutics, Inc.
Adam Brausa

Great content, I gained a lot.

Adam Brausa
Morrison Foerster
Asim Abdul

The forum offered strong insight into the mRNA platform.

Asim Abdul
GSK